ArticleJournal of hematology & oncology2024

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Dirk Hose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.